Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: J Cyst Fibros. 2021 Feb 8;20(6):965–971. doi: 10.1016/j.jcf.2021.01.011

Figure 3. CHEC-SC Study Design.

Figure 3.

Individuals with CF are eligible if on a commercially available CFTR modulator for at least three months. A single study visit is completed with sweat chloride measurement and data collection. Data from the CFF Patient Registry is collected to determine long term outcomes. Patients may re-enroll if an alternative CFTR modulator is initiated.